Provided by Tiger Trade Technology Pte. Ltd.

Xencor

27.80
+0.80002.96%
Pre-market: 28.390.5900+2.12%08:55 EDT
Volume:753.11K
Turnover:20.90M
Market Cap:2.06B
PE:-12.77
High:28.16
Open:27.30
Low:27.07
Close:27.00
52wk High:28.16
52wk Low:7.71
Shares:74.13M
Float Shares:54.25M
Volume Ratio:0.54
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1768
EPS(LYR):-1.2400
ROE:-29.07%
ROA:-16.83%
PB:4.10
PE(LYR):-22.42

Loading ...

Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential

TIPRANKS
·
May 06

Xencor to host webcast to discuss XmAb942, XmAb412 data presentations

TIPRANKS
·
May 04

Xencor schedules Phase 2b XmAb942 ulcerative colitis trial 12-week results for 2027

Reuters
·
May 04

Xencor announces annual shareholder meeting

Reuters
·
Apr 28

Top Xencor Executive Quietly Cashes Out a Chunk of Company Stock

TIPRANKS
·
Apr 14

Xencor Shares Fall After JPMorgan Downgrade

MT Newswires Live
·
Mar 25

Xencor Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
Mar 24

JPMorgan Downgrades Xencor to Neutral From Overweight, Adjusts PT to $13 From $18

MT Newswires Live
·
Mar 24

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Xencor (XNCR)

TIPRANKS
·
Mar 24

Xencor downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 24

Xencor Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $13 From $18

THOMSON REUTERS
·
Mar 24

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco

Reuters
·
Mar 24

Xencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors

TIPRANKS
·
Mar 14

Xencor, Genentech to End Protein Therapeutics Collaboration

TIPRANKS
·
Mar 10

Genentech Terminates Collaboration Agreement With Xencor

Dow Jones
·
Mar 10

Xencor reports receipt of notice of termination of license agreement from Roche

TIPRANKS
·
Mar 10

Xencor (XNCR) Receives a Buy from Wedbush

TIPRANKS
·
Mar 05

Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Stryker (SYK) and Xencor (XNCR)

TIPRANKS
·
Mar 05

Xencor: Buy Rating Reaffirmed on Pipeline Momentum Despite Ultomiris Royalty Headwind

TIPRANKS
·
Mar 05

Xencor Says Licensee Will Stop Paying U.S. Royalties, Lowers Cash Outlook

Dow Jones
·
Mar 05